Location: Home
  • search
  • go
  • Relate News
  • 4/17/2018JHL Files Clinical Trial Application for Avastin (Bevacizumab) Biosimi...
  • 4/16/2018China to Roll Out New Measures to Boost Internet + Healthcare
  • 4/16/2018China to Set Up Hainan Free Trade Zone, Further Benefiting Medical Tou...
  • 4/16/2018Opdivo (Nivolumab) Improves Survival in Pretreated Chinese NSCLC Patie...
  • 4/13/2018State Council Removes Import Duties on Anticancers as It Proposes New ...
  • 4/13/2018Top A Share-listed Chinese Pharma Companies by R&D Investment 2017
  • 4/13/2018CNDA Issues New Announcement (2018#2) for Clinical Data Self-Inspectio...
  • 4/13/2018CNDA Publishes 2017 Annual Report for Adverse Drug Reaction Monitoring
  • 4/13/2018State Council Lays Out Tasks in Healthcare and Pharmaceutical System R...
  • 4/13/2018CANbridge Receives IND Approval to Commence CAN008 Phase II/III Trial ...
  • 4/12/2018Nicholas Hall Projects Chinese OTC Drug Market to Grow 6% CAGR in the ...
  • 4/12/2018Nicholas Hall's Review of China's OTC Drug Market Performance 2017
  • 4/12/2018China's Relatively Small Central Government Healthcare Budget Surge 55...
  • 4/12/2018Bloomburg: China Is Nationalizing Its Tech Sector
  • 4/12/2018Chinese Investor Group Snaps Up Majority of Nature's Care for $620M
  • 4/12/2018Klockner Pentaplast Expands Pharma Capacity in China
  • 4/11/2018BeiGene Initiates Global Phase 2 Trial of Anti-PD-1 Antibody Tislelizu...
  • 4/10/2018SMEI: Review of Chinese Terminal Drug Markets in 2010-2017
  • 4/10/2018Biologic Consumption Patterns in Medical Institutions of Shanghai
  • 4/10/2018Review of CDE-Accepted Class 1 New Drugs in 2017
  • 4/10/2018NCC Publishes the Latest National Cancer Statistics
  • 4/10/2018New Study: China Has Almost 100 million COPD Patients
  • 4/10/2018PharmExec: China's CAR-T Therapy Race
  • 4/9/2018Chinese Performance of MNC Pharma Companies Up 10% in 2017
  • 4/6/2018Recent Executive Moves
  • 4/6/2018China Pushes Generics over Brands with Another Round of New Pharma Pol...
  • 4/6/2018Biopharma Caught in the Crosshairs of U.S.-China Trade Tussle
  • 4/6/2018Frontage Acquires CRO Preclinical Concord Biosciences to Expand Offeri...
  • 4/6/2018Lilly Offloads All Three NASH Programs to LAV-backed Terns Pharma
  • 4/6/2018China to Restructure and Consolidate IP Regulatory Authorities
  • Page:273/720 Total number of articles:21578: [First][<<] [271] [272] [273] [274] [275] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group